Krishna Sundar, MD
Sleep Medicine · Provo, UTNPI 1801802186
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by GSK at 52.9% of the total. Reporting peaked in 2024 at $11,278 and has fallen 96.1% since, to $440 in 2025.
Across 41 payments — averaging $423.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$9K
- Merck$4K
- Inspire Medical Systems, Inc.$3K
- Resmed Corp$797
- Takeda Pharmaceuticals U.S.A., Inc.$192
- Avadel CNS Pharmaceuticals, LLC$131
- plus $205 from 3 others
Across 68 payments — averaging $8120.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$461K
- GSK$91K
- Merck$61
What the payments were for
- Consulting fees$10,00058%
- Travel & lodging$5,88034%
- Food & beverage$1,4718%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $9,183 |
| Merck | 4 | $4,031 |
| Inspire Medical Systems, Inc. | 16 | $2,822 |
| Resmed Corp | 2 | $797 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $192 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $131 |
| Harmony Biosciences LLC | 2 | $98 |
| Eisai Inc. | 1 | $91 |
| Livanova USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,863
- AIR 11$780
- Inspire Upper Airway Stimulation System$684
- LUMRYZ$131
How this compares
$17,362 in reported general payments places this provider in the 80th percentile of 20 sleep medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 21 | $1,685 |
| Omeprazole | 22 | $260 |
| Gabapentin | 13 | $244 |
| Diazepam | 12 | $97 |
| Eszopiclone | 11 | $84 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Provo
- John StaheliProvo$9K
- Michael GalloProvo$2K
- Kirk WatkinsSt George$248K
- Seth WallaceLogan$118K
- Chitra LalSalt Lake City$94K
- Robert MazzolaSalt Lake City$12K
- Nicholas AndersonSalt Lake City$7K
- Sanjay KajiSalt Lake City$5K
- Garrett BirdRiverton$4K
- Matthew McKeeRoosevelt$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.